Dianthus Therapeutics, Inc. (DNTH) Discusses Interim Responder Analysis and Early Go Decision for CAPTIVATE Trial in CIDP Transcript

Core Viewpoint - Dianthus Therapeutics is conducting a conference call to discuss its latest developments and financial performance, indicating a focus on investor engagement and transparency [1] Company Overview - The call is led by Marino Garcia, the CEO of Dianthus Therapeutics, highlighting the leadership's role in communicating with investors [1] Presentation Details - A slide presentation is available on the Investors section of the Dianthus Therapeutics website, suggesting the company is providing additional resources for stakeholders to understand its performance and strategy [1] Q&A Session - The conference call will include a Q&A session following the prepared remarks, indicating an opportunity for investors to engage directly with the company's leadership [1]